The makers of the XSTAT hemostatic device, a syringe filled with tiny sponges used to stem excessive blood caused by a severe injury, has announced the first documented clinical use of the product since its release.
The injection, which is filled with tiny cellulose sponges that are coated in a coagulant and an antimicrobial called chitosan, was specially designed to help save bullet wound victims from excessive blood loss. Xstat was both approved by the FDA and began its first shipments to the US Military just last year. The XSTAT-30 device. Image courtesy…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
